SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : XOMA. Bull or Bear?
XOMA 24.61-4.3%Jan 28 3:59 PM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Bluegreen who wrote (7985)12/8/1998 10:33:00 PM
From: Robert K.  Read Replies (1) of 17367
 
I do have several long comments that I will greatly compress.
1. I do think the bermuda proposal does create uncertainty and I guess this creates a temporary weakness.
2. I do think that any artificial weakness (or strength) can be taken advantage of(given a long view).
3. I do think that investors have short memories and focus on recent events too much.
4. I do think that in the longrun far and away the significant
thing that matters to me is whether bpi products work or not.
5. I do think that clinicals will answer that question.
6. I do think that meningo will provide a hint but not the answer.
7. I do think that bpi is poorly understood.among both wall street and
the medical community in general.
8. I do refer to the preclinical results and conclusions often for guidance and context.
9. I do maintain a longterm view.
10. I do always disclaim everything.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News